American Health & Drug Benefits

Conference Correspondent

Pooled Analysis of Safety Data from Phase 2 and 3 Clinical Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections

Conference Correspondent - IDWeek 2018

Integrated Safety Summary of Omadacycline, A Novel Aminomethylcycline Antibiotic

Conference Correspondent - IDWeek 2018

The AMMO Study: Antimicrobial Management in Extracorporeal Membrane Oxygenation

Conference Correspondent - IDWeek 2018

Systematic Review and Network Meta-Analysis of Randomized Trials of Antibiotic Therapy for Community-Acquired Pneumonia

Conference Correspondent - IDWeek 2018

LEAP 2 Study Shows Oral Lefamulin Is Safe and Effective in Treatment of Adults with Community-Acquired Bacterial Pneumonia

Conference Correspondent - IDWeek 2018

Current Issue

Namaste

David B. Nash, MD, MBA

July 2018 Vol 11, No 5 - Editorial

Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States

Gilbert L. Queeley, PhD, Ellen S. Campbell, PhD, Askal A. Ali, PhD

July 2018 Vol 11, No 5 - Clinical, Original Research

Stakeholder Perspective

The Challenge of Maintaining Vascular Access in Patients with End-Stage Renal Disease

by Raymond L. Singer, MD, MMM, CPE

The Prevalence and Payer Costs of Potentially Avoidable Emergent Care Visits for Suspected Amniotic Membrane Rupture in Pregnant Women

Christine Ferro, CHFP, Bruce S. Pyenson, FSA, MAAA, Jocelyn Lau, MPH, Mona Kelkar, MBA, Nancy Phillips, MD, Chi-Wei Lu, PhD, Percy Yeung, PhD, Gloria Bachmann, MD

July 2018 Vol 11, No 5 - Business, Original Research

Stakeholder Perspective

Interventions to Reduce Avoidable Pregnancy-Related Emergency Department Visits

by Eliza Ng, MD

Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohn’s Disease

Michele Wilson, MSPH, Aaron Lucas, PhD, MPH;, Ann Cameron, MA, PhD;, Michelle Luo, PhD

July 2018 Vol 11, No 5 - Business, Original Research

Most Popular Articles

Unintended Consequences of Fluoroquinolone Stewardship: Impact on Overall Antimicrobial Use Data and Implications for Benchmarking

Conference Correspondent - IDWeek 2018

Oral Step-Down Therapy with Fluoroquinolones versus Beta-Lactams for Hospitalized Patients with Community-Acquired Pneumonia

Conference Correspondent - IDWeek 2018

Integrated Safety Summary of Omadacycline, A Novel Aminomethylcycline Antibiotic

Conference Correspondent - IDWeek 2018

Antimicrobial Stewardship Program Aims to Reduce Antimicrobial Usage in Geriatric Patients without Affecting Outcomes

Conference Correspondent - IDWeek 2018

Web Exclusives

Neratinib First Extended Adjuvant Treatment for Patients with Early-Stage, HER2-Positive Breast Cancer

HER2-positive breast cancers are aggressive tumors and can spread to other parts of the body, making adjuvant therapy an important part of the treatment plan.

Select Drug Updates

Yondelis (Trabectedin) Approved for the Treatment of Unresectable or Metastatic Soft-Tissue Sarcomas

Vyvanse (Lisdexamfetamine Dimesylate): First FDA-Approved Drug for the Treatment of Adults with Binge-Eating Disorder

Varubi (Rolapitant) Approved for the Prevention of Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

Tagrisso (Osimertinib) Approved for Patients with Non–Small-Cell Lung Cancer and the EGFR T790M Mutation

View All Updates

Conference Correspondent

Current Issue

Most Popular Articles

Web Exclusives

Select Drug Updates

Reader Poll